| NCT03373396 |
Impact of Chlordecone on Active Chronic Hepatitis |
https://ClinicalTrials.gov/show/NCT03373396 |
Completed |
Centre Hospitalier Universitaire de Pointe-a-Pitre |
2015-12-21 |
| NCT03258710 |
A Study of Switching From Entecavir to Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03258710 |
Completed |
GlaxoSmithKline |
2018-12-28 |
| NCT03241641 |
Switching From TDF to TAF vs. Maintaining TDF in Chronic Hepatitis B With Resistance to Adefovir or Entecavir. |
https://ClinicalTrials.gov/show/NCT03241641 |
Active, not recruiting |
Asan Medical Center |
2020-03-31 |
| NCT03235349 |
Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-Infection |
https://ClinicalTrials.gov/show/NCT03235349 |
Completed |
AbbVie |
2018-11-15 |
| NCT03222583 |
A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection |
https://ClinicalTrials.gov/show/NCT03222583 |
Completed |
AbbVie |
2018-10-18 |
| NCT03219216 |
A Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults in Brazil With Chronic Hepatitis C Virus (HCV) Genotype 1 - 6 Infection |
https://ClinicalTrials.gov/show/NCT03219216 |
Completed |
AbbVie |
2019-03-11 |
| NCT03188276 |
The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAs |
https://ClinicalTrials.gov/show/NCT03188276 |
Completed |
Third Affiliated Hospital, Sun Yat-Sen University |
2017-05-01 |
| NCT03180619 |
Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV) |
https://ClinicalTrials.gov/show/NCT03180619 |
Active, not recruiting |
Gilead Sciences |
2019-03-27 |
| NCT03180333 |
The Tolerability and Pharmacokinetics Clinical Trial of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers |
https://ClinicalTrials.gov/show/NCT03180333 |
Completed |
Guangzhou Yipinhong Pharmaceutical CO.,LTD |
2012-08-31 |
| NCT03173599 |
The Safety and Tolerability of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers |
https://ClinicalTrials.gov/show/NCT03173599 |
Completed |
Guangzhou Yipinhong Pharmaceutical CO.,LTD |
2011-04-30 |
| NCT03163849 |
Assessment Effects After Direct Acting Antiviral in Chronic Hepatitis c Virus Patients |
https://ClinicalTrials.gov/show/NCT03163849 |
Active, not recruiting |
Assiut University |
2020-06-01 |
| NCT03109730 |
Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03109730 |
Completed |
Assembly Biosciences |
2018-03-31 |
| NCT03089944 |
A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT03089944 |
Completed |
AbbVie |
2019-07-31 |
| NCT03069365 |
A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal Impairment |
https://ClinicalTrials.gov/show/NCT03069365 |
Completed |
AbbVie |
2018-02-20 |
| NCT03067129 |
A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection |
https://ClinicalTrials.gov/show/NCT03067129 |
Active, not recruiting |
AbbVie |
2020-02-18 |
| NCT03038113 |
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of RO7062931in Healthy Volunteers and Subjects With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03038113 |
Completed |
Hoffmann-La Roche |
2019-10-18 |
| NCT03036852 |
Sofosbuvir/Velpatasvir in Adults With Chronic Hepatitis C Virus Infection Who Are on Dialysis for End Stage Renal Disease |
https://ClinicalTrials.gov/show/NCT03036852 |
Completed |
Gilead Sciences |
2018-08-13 |
| NCT03020745 |
A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3389404 in Chronic Hepatitis B (CHB) Subjects |
https://ClinicalTrials.gov/show/NCT03020745 |
Completed |
GlaxoSmithKline |
2019-01-28 |
| NCT03020095 |
Efficacy and Safety of Ravidasvir + Danoprevir/r 12-week Oral Therapy in Treatment-Naive Non Cirrhotic G1 CHC Taiwan |
https://ClinicalTrials.gov/show/NCT03020095 |
Completed |
Ascletis Pharmaceuticals Co., Ltd. |
2016-08-31 |
| NCT03020082 |
Efficacy and Safety of Danoprevir/r + PR 12week Triple Therapy in Treatment Naive Non-Cirrhotic G1 CHC China III |
https://ClinicalTrials.gov/show/NCT03020082 |
Completed |
Ascletis Pharmaceuticals Co., Ltd. |
2017-05-31 |
| NCT03020004 |
Efficacy and Safety of Danoprevir/r + PR 12-week Triple Therapy in Treatment-Naive, Non-Cirrhotic, G1 CHC China II |
https://ClinicalTrials.gov/show/NCT03020004 |
Completed |
Ascletis Pharmaceuticals Co., Ltd. |
2016-11-30 |
| NCT03013556 |
Study on an Optimal Antiviral Treatment in HBeAg Positive Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT03013556 |
Recruiting |
Ruijin Hospital |
2020-06-30 |
| NCT02992704 |
Peg-interferon for Inactive Chronic Hepatitis B Carriers |
https://ClinicalTrials.gov/show/NCT02992704 |
Active, not recruiting |
National University Health System, Singapore |
2019-08-31 |
| NCT02991638 |
Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers |
https://ClinicalTrials.gov/show/NCT02991638 |
Recruiting |
The University of Hong Kong |
2020-12-31 |
| NCT02972723 |
Metformin Therapy in HCV Infection |
https://ClinicalTrials.gov/show/NCT02972723 |
Completed |
Nottingham University Hospitals NHS Trust |
2011-09-30 |
| NCT02971033 |
Ezetimibe as a Safe and Efficacious Treatment for Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT02971033 |
Recruiting |
VA Office of Research and Development |
2021-03-31 |
| NCT02908191 |
A Study in Healthy Volunteers and Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT02908191 |
Completed |
Assembly Biosciences |
2018-03-31 |
| NCT02881008 |
Myrcludex B vs Entecavir in Patients With HBeAg Negative Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT02881008 |
Completed |
Hepatera Ltd. |
2014-10-04 |
| NCT02862548 |
Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF)-Containing Regimens in Participants With Chronic Hepatitis B Virus (HBV) Infection and Stage 2 or Greater Chronic Kidney Disease Who Have Received a Liver Transplant |
https://ClinicalTrials.gov/show/NCT02862548 |
Active, not recruiting |
Gilead Sciences |
2018-02-08 |
| NCT02845401 |
The “HBV e-Antigen Negative Disease-Directly Offers” Study: Treatment Withdrawal in Patients With Early-Antigen Negative Chronic HBV |
https://ClinicalTrials.gov/show/NCT02845401 |
Active, not recruiting |
California Pacific Medical Center Research Institute |
2021-11-17 |
| NCT02838810 |
The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg |
https://ClinicalTrials.gov/show/NCT02838810 |
Recruiting |
Third Affiliated Hospital, Sun Yat-Sen University |
2019-12-31 |
| NCT02823457 |
VBMI to Increase Treatment Completion With MK-MK-5172/MK-8742 Among Veterans With Active Substance Use Disorders Genotype 1 Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT02823457 |
Completed |
G.V. (Sonny) Montgomery VA Medical Center |
2020-01-30 |
| NCT02792088 |
Study to Assess the Antiviral Activity and Safety Endpoints for the Treatment of Besifovir 150mg Compared to Tenofovir 300mg in Chronic Hepatitis B Patients Who Have Resistance to Nucleoside Analogues |
https://ClinicalTrials.gov/show/NCT02792088 |
Recruiting |
IlDong Pharmaceutical Co Ltd |
2019-03-31 |
| NCT02774837 |
Tenofovir Versus Tenofovir + Telbivudine for Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT02774837 |
Active, not recruiting |
National University Health System, Singapore |
2020-07-31 |
| NCT02772003 |
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT02772003 |
Active, not recruiting |
National Cancer Institute (NCI) |
2020-03-04 |
| NCT02745704 |
The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg |
https://ClinicalTrials.gov/show/NCT02745704 |
Recruiting |
Third Affiliated Hospital, Sun Yat-Sen University |
2019-04-30 |
| NCT02738554 |
Off Treatment Durability in Chronic Hepatitis B With Good Immune Control |
https://ClinicalTrials.gov/show/NCT02738554 |
Completed |
The University of Hong Kong |
2020-01-31 |
| NCT02738138 |
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2) |
https://ClinicalTrials.gov/show/NCT02738138 |
Completed |
AbbVie |
2017-03-15 |
| NCT02723084 |
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT02723084 |
Completed |
AbbVie |
2017-01-19 |
| NCT02707952 |
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT02707952 |
Completed |
AbbVie |
2016-11-14 |
| NCT02692703 |
A Study to Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients With Chronic Hepatitis C Virus (MAGELLAN-2) |
https://ClinicalTrials.gov/show/NCT02692703 |
Completed |
AbbVie |
2017-04-13 |
| NCT02662712 |
A Study of Orally Administered JNJ-56136379 to Evaluate Safety, Tolerability and Pharmacokinetics After Single Ascending Doses and One Multiple Dose Regimen in Healthy Participants (Part I), and After Multiple Dose Regimens in Participants With Chronic Hepatitis B (Part II) |
https://ClinicalTrials.gov/show/NCT02662712 |
Completed |
Janssen Sciences Ireland UC |
2018-06-29 |
| NCT02651194 |
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Renally Impaired Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection |
https://ClinicalTrials.gov/show/NCT02651194 |
Completed |
AbbVie |
2016-10-31 |
| NCT02640482 |
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus (HCV) Genotype 2 Infection |
https://ClinicalTrials.gov/show/NCT02640482 |
Completed |
AbbVie |
2016-09-30 |
| NCT02640157 |
A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 Infection |
https://ClinicalTrials.gov/show/NCT02640157 |
Completed |
AbbVie |
2016-10-31 |
| NCT02609659 |
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT02609659 |
Completed |
AbbVie |
2016-10-07 |
| NCT02604017 |
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection |
https://ClinicalTrials.gov/show/NCT02604017 |
Completed |
AbbVie |
2017-01-31 |
| NCT02589457 |
Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® Tablet |
https://ClinicalTrials.gov/show/NCT02589457 |
Completed |
Chong Kun Dang Pharmaceutical |
2015-12-31 |
| NCT02576314 |
Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT3 Infected Patients |
https://ClinicalTrials.gov/show/NCT02576314 |
Completed |
Humanity and Health Research Centre |
2017-12-31 |
| NCT02569710 |
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of the Combination of AL-335, Odalasvir, and Simeprevir |
https://ClinicalTrials.gov/show/NCT02569710 |
Completed |
Alios Biopharma Inc. |
2018-05-11 |
| NCT02569372 |
A Phase 1 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT02569372 |
Completed |
Green Cross Corporation |
2017-10-12 |
| NCT02565719 |
REP 2139-Mg and REP 2165-Mg Combination Therapy in Chronic Hepatitis B Infection |
https://ClinicalTrials.gov/show/NCT02565719 |
Completed |
Replicor Inc. |
2019-05-31 |
| NCT02932150 |
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT02932150 |
Recruiting |
Gilead Sciences |
2023-02-28 |
| NCT02517528 |
ABT-450/Ritonavir/ ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-Administered With Ribavirin (RBV) in Treatment Naïve and Treatment Experienced Asian Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Compensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT02517528 |
Completed |
AbbVie |
2016-09-29 |
| NCT02517515 |
ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Treatment-Naïve and Treatment-Experienced, Non-Cirrhotic Asian Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) Infection |
https://ClinicalTrials.gov/show/NCT02517515 |
Completed |
AbbVie |
2016-10-31 |
| NCT02493855 |
Ombitasvir/ABT-450/Ritonavir and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naive Genotype 1a Hepatitis C Virus Infected Adults |
https://ClinicalTrials.gov/show/NCT02493855 |
Completed |
AbbVie |
2016-04-30 |
| NCT02486406 |
A Study to Evaluate Treatment of Hepatitis C Virus Infection in Pediatric Subjects |
https://ClinicalTrials.gov/show/NCT02486406 |
Active, not recruiting |
AbbVie |
2020-11-26 |
| NCT02482077 |
Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT2 Infected Patients |
https://ClinicalTrials.gov/show/NCT02482077 |
Completed |
Humanity and Health Research Centre |
2017-12-31 |
| NCT02468648 |
Viral Kinetics, Interferon Stimulated Genes (ISGs) and mirRNA Among Subjects Infected With Different Hepatitis C Virus Genotypes During Therapy With Sofosbuvir and GS-5816 |
https://ClinicalTrials.gov/show/NCT02468648 |
Completed |
National Institutes of Health Clinical Center (CC) |
2018-09-14 |
| NCT02446717 |
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With HCV Who Failed a Prior DAA Containing Therapy |
https://ClinicalTrials.gov/show/NCT02446717 |
Completed |
AbbVie |
2016-12-31 |
| NCT02442284 |
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in US Veterans With Genotype 1 Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT02442284 |
Completed |
AbbVie |
2016-08-22 |
| NCT02442271 |
A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs in Adults With Hepatitis C Virus Infection, Who Are Either Treatment-naive or Treatment-experienced in Brazil |
https://ClinicalTrials.gov/show/NCT02442271 |
Completed |
AbbVie |
2016-07-04 |
| NCT02439567 |
Transient Elastography to Assess Liver Fibrosis and Portal Hypertension in HCV Cirrhotic Patients Treated With New Antiviral Drugs (SPLEEN-C) |
https://ClinicalTrials.gov/show/NCT02439567 |
Completed |
Hospital Universitari Vall d’Hebron Research Institute |
2016-07-31 |
| NCT02401737 |
Dose-Ranging Study to Assess the Safety, PK and Initial Antiviral Efficacy of NVR 3-778 in Chronic HBV Patients |
https://ClinicalTrials.gov/show/NCT02401737 |
Completed |
Novira Therapeutics, Inc. |
2016-05-18 |
| NCT02399345 |
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Co-Administered With Sofosbuvir With and Without Ribavirin in Treatment-Naive HCV Genotype 1-Infected Adults |
https://ClinicalTrials.gov/show/NCT02399345 |
Completed |
AbbVie |
2015-11-30 |
| NCT02364336 |
Add-on Peginterferon Following Nucleos(t)Ide Analogue Treatment |
https://ClinicalTrials.gov/show/NCT02364336 |
Completed |
National Institutes of Health Clinical Center (CC) |
2018-05-21 |
| NCT02356562 |
A Study of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Sofosbuvir and Ribavirin in Direct-Acting Antiviral Agent Treatment-Experienced Adults With Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT02356562 |
Completed |
AbbVie |
2016-10-28 |
| NCT02355951 |
Non-investigational Study to Evaluate Adenovirus Serotype 5 (Ad5) Neutralizing Antibodies (nAb) in Patients With Chronic Hepatitis B Virus (HBV) Mono-infection |
https://ClinicalTrials.gov/show/NCT02355951 |
Completed |
Transgene |
2016-02-29 |
| NCT02349048 |
Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection |
https://ClinicalTrials.gov/show/NCT02349048 |
Completed |
Janssen Research & Development, LLC |
2016-02-29 |
| NCT02339207 |
First in Human Study of AL-335; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1 |
https://ClinicalTrials.gov/show/NCT02339207 |
Completed |
Alios Biopharma Inc. |
2016-05-31 |
| NCT02332473 |
A Prospective Study of Combination of Peginterferon Alfa-2b (40kD, Y-shape) and GM-CSF in Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT02332473 |
Completed |
Xiamen Amoytop Biotech Co., Ltd. |
2016-02-29 |
| NCT02292719 |
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT02292719 |
Completed |
AbbVie |
2017-07-14 |
| NCT02287857 |
Efficacy and Safety of Domestic Tenofovir Tablets in Chinese Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT02287857 |
Recruiting |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2019-10-31 |
| NCT02265237 |
A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (AGATE-1) |
https://ClinicalTrials.gov/show/NCT02265237 |
Completed |
AbbVie |
2016-07-28 |
| NCT02263079 |
A Study of Pegylated Interferon Alfa-2A in Combination With Lamivudine or Entecavir Compared With Untreated Control Group in Children With Hepatitis B Envelope Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) in the Immune-Tolerant Phase |
https://ClinicalTrials.gov/show/NCT02263079 |
Completed |
Hoffmann-La Roche |
2020-01-29 |
| NCT02250807 |
Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT02250807 |
Completed |
Janssen R&D Ireland |
2015-12-31 |
| NCT02249988 |
Clinical Efficacy of ABX203 Therapeutic Vaccine in HBeAg Negative Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT02249988 |
Completed |
Abivax S.A. |
2016-12-31 |
| NCT02243293 |
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection |
https://ClinicalTrials.gov/show/NCT02243293 |
Completed |
AbbVie |
2016-10-25 |
| NCT02243280 |
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-administration of ABT-493 and ABT-530 With and Without Ribavirin in Subjects With HCV Genotype 1, 4, 5, and 6 Infection |
https://ClinicalTrials.gov/show/NCT02243280 |
Completed |
AbbVie |
2016-02-29 |
| NCT02224456 |
Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT02224456 |
Active, not recruiting |
GlaxoSmithKline |
2020-12-02 |
| NCT02219503 |
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis |
https://ClinicalTrials.gov/show/NCT02219503 |
Completed |
AbbVie |
2015-06-30 |
| NCT02219490 |
A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection |
https://ClinicalTrials.gov/show/NCT02219490 |
Active, not recruiting |
AbbVie |
2021-05-12 |
| NCT02219477 |
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT02219477 |
Completed |
AbbVie |
2016-06-13 |
| NCT02216422 |
A Study to Evaluate Chronic Hepatitis C Virus (HCV) Infection in Cirrhotic Adults With Genotype 1b (GT1b) Infection |
https://ClinicalTrials.gov/show/NCT02216422 |
Completed |
AbbVie |
2015-12-31 |
| NCT02216045 |
Effect of Camel Milk on Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT02216045 |
Completed |
Mashhad University of Medical Sciences |
2015-02-28 |
| NCT02207088 |
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease |
https://ClinicalTrials.gov/show/NCT02207088 |
Completed |
AbbVie |
2016-12-06 |
| NCT02203149 |
Study of Grazoprevir (MK-5172) and Elbasvir (MK-8742) in Japanese Participants With Chronic Hepatitis C (MK-5172-058) |
https://ClinicalTrials.gov/show/NCT02203149 |
Completed |
Merck Sharp & Dohme Corp. |
2015-10-02 |
| NCT02202473 |
Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected Subjects |
https://ClinicalTrials.gov/show/NCT02202473 |
Completed |
Southeast University, China |
2014-02-28 |
| NCT02195518 |
Tenofovir Disoproxil Fumarate (TDF) 300mg 3 Years RD Therapy Chinese Chronic Hepatitis B (CHN) CHB Multiple Nucleos(t)Ide Analogues (NAs) Failure Points Pts PH4 PMS Study |
https://ClinicalTrials.gov/show/NCT02195518 |
Completed |
GlaxoSmithKline |
2018-08-14 |
| NCT02174276 |
Safety and Efficacy of GS-4774 in Combination With Tenofovir Disoproxil Fumarate (TDF) for the Treatment of Participants With Chronic Hepatitis B (CHB) and Who Are Currently Not on Treatment |
https://ClinicalTrials.gov/show/NCT02174276 |
Completed |
Gilead Sciences |
2016-02-17 |
| NCT02168361 |
The SIM-SOF Trial for Hepatitis C |
https://ClinicalTrials.gov/show/NCT02168361 |
Completed |
Center For Hepatitis C, Atlanta, GA |
2014-12-31 |
| NCT02167945 |
A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection |
https://ClinicalTrials.gov/show/NCT02167945 |
Active, not recruiting |
AbbVie |
2021-05-12 |
| NCT02166047 |
Safety and Efficacy of GS-9620 for the Treatment of Chronic Hepatitis B Virus in Virally-Suppressed Subjects |
https://ClinicalTrials.gov/show/NCT02166047 |
Completed |
Gilead Sciences |
2016-05-31 |
| NCT02118012 |
Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl in Patients With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT02118012 |
Completed |
National Institutes of Health Clinical Center (CC) |
2014-03-20 |
| NCT02115321 |
Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Chronic Hepatitis C Participants With Child-Pugh (CP)-B Hepatic Insufficiency (MK-5172-059) |
https://ClinicalTrials.gov/show/NCT02115321 |
Completed |
Merck Sharp & Dohme Corp. |
2015-03-05 |
| NCT02112799 |
Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT02112799 |
Completed |
Novira Therapeutics, Inc. |
2016-05-18 |
| NCT02105688 |
An Efficacy and Safety Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in the Treatment of Chronic Hepatitis C Virus (HCV) Genotype (GT)1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062) |
https://ClinicalTrials.gov/show/NCT02105688 |
Completed |
Merck Sharp & Dohme Corp. |
2015-06-10 |
| NCT02105662 |
An Efficacy and Safety Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in the Treatment of Chronic Hepatitis C Virus in Participants Who Are Co-Infected With Human Immunodeficiency Virus:C-EDGE CO-INFXN (MK-5172-061) |
https://ClinicalTrials.gov/show/NCT02105662 |
Completed |
Merck Sharp & Dohme Corp. |
2015-02-20 |
| NCT02105467 |
Study of Efficacy and Safety of Grazoprevir (MK-5172)/Elbasvir (MK-8742) Combination Regimen for Treatment-Naïve Participants With Chronic Hepatitis C Virus Genotypes 1, 4, and 6 (MK-5172-060) |
https://ClinicalTrials.gov/show/NCT02105467 |
Completed |
Merck Sharp & Dohme Corp. |
2015-02-26 |
| NCT02094443 |
Alisporivir With RBV in Chronic Hepatitis C Genotype 2 and 3 Participants for Whom Interferon is Not an Option |
https://ClinicalTrials.gov/show/NCT02094443 |
Completed |
Debiopharm International SA |
2015-04-30 |
| NCT02068222 |
A Study to Evaluate the Safety and Antiviral Effect of ABT-450/Ritonavir and ABT-530 Coadministered With and Without Ribavirin in Adults With Genotype 3 Hepatitis C (HCV) Infection |
https://ClinicalTrials.gov/show/NCT02068222 |
Completed |
AbbVie |
2015-03-31 |
| NCT01314261 |
Study of ABT-267 in Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Infected Subjects |
https://ClinicalTrials.gov/show/NCT01314261 |
Completed |
AbbVie |
2012-01-31 |
| NCT01306617 |
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-333 and Ribavirin (RBV) in Treatment-Naïve and Non-responder Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection |
https://ClinicalTrials.gov/show/NCT01306617 |
Completed |
AbbVie |
2011-11-30 |
| NCT01290965 |
Safety, PK and Efficacy of 15 Days of SCY-635 Treatment in Hepatitis C Patients |
https://ClinicalTrials.gov/show/NCT01290965 |
Completed |
Scynexis, Inc. |
2008-12-31 |
| NCT01277601 |
Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01277601 |
Completed |
Gilead Sciences |
2014-08-31 |
| NCT01276756 |
Efficacy of Nitazoxanide in the Treatment of Chronic Hepatitis C Virus (HCV) |
https://ClinicalTrials.gov/show/NCT01276756 |
Completed |
Cairo University |
2012-11-30 |
| NCT02023099 |
Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) in Japanese Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) Infection |
https://ClinicalTrials.gov/show/NCT02023099 |
Completed |
AbbVie |
2014-10-31 |
| NCT03753074 |
Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current Guidelines |
https://ClinicalTrials.gov/show/NCT03753074 |
Recruiting |
Asan Medical Center |
2023-12-31 |
| NCT01651403 |
Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Participants With Chronic Hepatitis B Infection |
https://ClinicalTrials.gov/show/NCT01651403 |
Active, not recruiting |
Gilead Sciences |
2017-08-07 |
| NCT03357822 |
A Real-World Study of Pegylated Interferon In Nucleoside-treated Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03357822 |
Recruiting |
Tongji Hospital |
2022-01-25 |
| NCT03356834 |
Change of Renal Function and Bone Mineral Density in CHB Patients Switch From TDF to TAF vs. Maintaining TDF |
https://ClinicalTrials.gov/show/NCT03356834 |
Recruiting |
Humanity and Health Research Centre |
2022-10-31 |
| NCT02014571 |
Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C. |
https://ClinicalTrials.gov/show/NCT02014571 |
Completed |
GlaxoSmithKline |
2014-07-03 |
| NCT01997944 |
Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein Phase Ib Study in Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT01997944 |
Completed |
Beijing Bio-Fortune Ltd. |
2014-09-30 |
| NCT01995071 |
A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV) |
https://ClinicalTrials.gov/show/NCT01995071 |
Completed |
AbbVie |
2015-06-30 |
| NCT01970904 |
Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients |
https://ClinicalTrials.gov/show/NCT01970904 |
Completed |
Debiopharm International SA |
2015-03-31 |
| NCT01951209 |
Pilot Study Of The Effect Of Rifaximin On B-Cell Dysregulation In Cirrhosis |
https://ClinicalTrials.gov/show/NCT01951209 |
Active, not recruiting |
Corporal Michael J. Crescenz VA Medical Center |
2018-08-31 |
| NCT01939197 |
A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection |
https://ClinicalTrials.gov/show/NCT01939197 |
Completed |
AbbVie |
2016-07-21 |
| NCT01938625 |
A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation |
https://ClinicalTrials.gov/show/NCT01938625 |
Completed |
Janssen R&D Ireland |
2015-04-27 |
| NCT01937806 |
Phase 3 and Extensional Study of Besifovir |
https://ClinicalTrials.gov/show/NCT01937806 |
Active, not recruiting |
IlDong Pharmaceutical Co Ltd |
2016-02-29 |
| NCT01928511 |
Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral Therapy |
https://ClinicalTrials.gov/show/NCT01928511 |
Completed |
National University Health System, Singapore |
2018-12-31 |
| NCT01913431 |
Baracle Tab. ® Versus Baraclude Tab.® for Patients With HBeAg Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01913431 |
Completed |
Dong-A ST Co., Ltd. |
2015-11-06 |
| NCT01911845 |
An Open-label, Single Arm, Phase 2 Study to Evaluate ABT-450/r/ABT-267 and ABT-333 With Ribavirin (RBV) in Adults With Genotype 1 HCV Infection Taking Methadone or Buprenorphine |
https://ClinicalTrials.gov/show/NCT01911845 |
Completed |
AbbVie |
2013-12-31 |
| NCT01908335 |
A Phase â…¡ Dose-escalating Study of PEG-IFN-SA and Ribavirin in IFN Naive Patients With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01908335 |
Completed |
Beijing Kawin Technology Share-Holding Co., Ltd. |
2013-08-31 |
| NCT01903278 |
Efficacy and Safety Study of PEG-IFN-SA and Ribavirin to Treat Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01903278 |
Completed |
Beijing Kawin Technology Share-Holding Co., Ltd. |
2015-08-31 |
| NCT01899092 |
Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01899092 |
Completed |
Tacere Therapeutics, Inc. |
2016-09-30 |
| NCT01892241 |
Efficacy and Safety of Peginterferon a-2a in Patients of Chronic Hepatitis B With Spontaneous Decline of HBV DNA |
https://ClinicalTrials.gov/show/NCT01892241 |
Completed |
Third Affiliated Hospital, Sun Yat-Sen University |
2012-11-30 |
| NCT01888900 |
New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01888900 |
Completed |
National Institutes of Health Clinical Center (CC) |
2015-11-30 |
| NCT01887275 |
A Control Study to Evaluate The Efficacy And Safety of Ozone-therapy in Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01887275 |
Completed |
Nanfang Hospital of Southern Medical University |
2013-02-28 |
| NCT01859962 |
Study of PPI-668, BI 207127 and Faldaprevir, With and Without Ribavirin, in the Treatment of Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01859962 |
Completed |
Presidio Pharmaceuticals, Inc. |
2014-05-31 |
| NCT01854697 |
A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before |
https://ClinicalTrials.gov/show/NCT01854697 |
Completed |
AbbVie |
2014-11-30 |
| NCT01854528 |
A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) for Treatment of Chronic Hepatitis C Infection in Treatment-experienced Adults |
https://ClinicalTrials.gov/show/NCT01854528 |
Completed |
AbbVie |
2014-11-30 |
| NCT01852604 |
Samatasvir (IDX719) in Combinations With Simeprevir and/or TMC647055/Ritonavir With or Without Ribavirin for 12 Weeks in Participants With Chronic Hepatitis C Infection (MK-1894-005) |
https://ClinicalTrials.gov/show/NCT01852604 |
Completed |
Merck Sharp & Dohme Corp. |
2015-04-30 |
| NCT01842451 |
A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-135 and Daclatasvir in Subjects With Genotype 1 Chronic Hepatitis C Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01842451 |
Completed |
Vertex Pharmaceuticals Incorporated |
2014-05-31 |
| NCT01833533 |
A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1a Infection |
https://ClinicalTrials.gov/show/NCT01833533 |
Completed |
AbbVie |
2013-12-31 |
| NCT01817725 |
Hepatitis B Vaccine in Chronic Hepatitis B Patients With Low Serum HBsAg |
https://ClinicalTrials.gov/show/NCT01817725 |
Completed |
Chang Gung Memorial Hospital |
2016-02-29 |
| NCT01790100 |
A Phase 2a, Dose-Ranging Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01790100 |
Completed |
Alios Biopharma Inc. |
2014-06-30 |
| NCT01782495 |
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients |
https://ClinicalTrials.gov/show/NCT01782495 |
Completed |
AbbVie |
2016-11-02 |
| NCT01767116 |
A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1b Infection |
https://ClinicalTrials.gov/show/NCT01767116 |
Completed |
AbbVie |
2013-12-31 |
| NCT01760122 |
Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01760122 |
Completed |
Xiamen Amoytop Biotech Co., Ltd. |
2015-07-31 |
| NCT01753570 |
Efficacy and Safety of MP-424, Interferon Beta (IFN Beta), and Ribavirin(RBV) in Treatment-Naïve or Having Received Interferon Based Therapy With Chronic Hepatitis C (CHC) |
https://ClinicalTrials.gov/show/NCT01753570 |
Completed |
Mitsubishi Tanabe Pharma Corporation |
2015-10-31 |
| NCT01740791 |
Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-5816 in Subjects With Chronic HCV Infection |
https://ClinicalTrials.gov/show/NCT01740791 |
Completed |
Gilead Sciences |
2014-01-31 |
| NCT01732367 |
TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNA |
https://ClinicalTrials.gov/show/NCT01732367 |
Completed |
Keimyung University Dongsan Medical Center |
2016-03-31 |
| NCT01728935 |
Tenofovir in Asian Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT01728935 |
Completed |
The University of Hong Kong |
2012-11-30 |
| NCT01726946 |
A Phase 2 Study to Evaluate the Safety and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01726946 |
Completed |
Vertex Pharmaceuticals Incorporated |
2014-02-28 |
| NCT01724086 |
A Study to Evaluate the Safety, Tolerability, and Effectiveness of a 12-Week Combination Therapy of TMC647055 and TMC435 With and Without GSK23336805 With a Pharmacokinetic Enhancer With and Without Ribavirin in Patients Infected With Chronic Genotype 1 Hepatitis C Virus |
https://ClinicalTrials.gov/show/NCT01724086 |
Completed |
Janssen R&D Ireland |
2014-09-30 |
| NCT01717560 |
Hepatitis C Treatment in Underserved Populations |
https://ClinicalTrials.gov/show/NCT01717560 |
Enrolling by invitation |
Weill Medical College of Cornell University |
2012-12-31 |
| NCT01716585 |
A Study to Evaluate Chronic Hepatitis C Infection |
https://ClinicalTrials.gov/show/NCT01716585 |
Completed |
AbbVie |
2013-10-31 |
| NCT01715415 |
A Study to Evaluate Chronic Hepatitis C Infection in Treatment Experienced Adults |
https://ClinicalTrials.gov/show/NCT01715415 |
Completed |
AbbVie |
2013-11-30 |
| NCT01711567 |
Tenofovir Disoproxil Fumarate vs. Entecavir in Chronic Hepatitis B Patients With Partial Virologic Response to Entecavir |
https://ClinicalTrials.gov/show/NCT01711567 |
Completed |
Korea University |
2015-12-31 |
| NCT01710501 |
A Study of Different Doses of Grazoprevir (MK-5172) Given With Pegylated Interferon Alfa-2b and Ribavirin to Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-038) |
https://ClinicalTrials.gov/show/NCT01710501 |
Completed |
Merck Sharp & Dohme Corp. |
2013-11-25 |
| NCT01708889 |
Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction |
https://ClinicalTrials.gov/show/NCT01708889 |
Completed |
Bristol-Myers Squibb |
2013-02-28 |
| NCT01704755 |
A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT01704755 |
Completed |
AbbVie |
2014-01-31 |
| NCT01700179 |
Evaluation of Safety Tolerability and Antiviral Activity of ACH-0143102 Plus RBV Treatment Naive HCV GT1b Subjects |
https://ClinicalTrials.gov/show/NCT01700179 |
Completed |
Alexion Pharmaceuticals |
2013-09-30 |
| NCT01687270 |
Safety and Efficacy of Sofosbuvir and Ribavirin in Adults With Recurrent Chronic Hepatitis C Virus (HCV) Post Liver Transplant |
https://ClinicalTrials.gov/show/NCT01687270 |
Completed |
Gilead Sciences |
2013-12-31 |
| NCT01686789 |
Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4 |
https://ClinicalTrials.gov/show/NCT01686789 |
Completed |
King Abdulaziz Medical City |
2015-08-31 |
| NCT01685203 |
A Study to Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT01685203 |
Completed |
AbbVie |
2014-06-30 |
| NCT01684787 |
Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive Patients |
https://ClinicalTrials.gov/show/NCT01684787 |
Completed |
Hospital Universitari de Bellvitge |
2011-05-31 |
| NCT01678131 |
Evaluating Fine Needle Aspiration to Measure Hepatic Vaniprevir (MK-7009) Concentrations in Participants With Chronic Hepatitis C (MK-7009-048) |
https://ClinicalTrials.gov/show/NCT01678131 |
Completed |
Merck Sharp & Dohme Corp. |
2013-08-27 |
| NCT01674725 |
A Study to Evaluate the Safety and Effect of the Experimental Drugs ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Subjects With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01674725 |
Completed |
AbbVie |
2014-01-31 |
| NCT01672983 |
A Study to Evaluate ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Japanese Adults With Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT01672983 |
Completed |
AbbVie |
2014-05-31 |
| NCT01671787 |
A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01671787 |
Completed |
Gilead Sciences |
2013-04-30 |
| NCT01609933 |
A Study to Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie/Abbott Combination Study |
https://ClinicalTrials.gov/show/NCT01609933 |
Completed |
AbbVie |
2017-05-03 |
| NCT01596517 |
Efficacy and Effectiveness of PegInterferon and Ribavirin in Korean Patients With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01596517 |
Completed |
Asan Medical Center |
2011-12-31 |
| NCT01581398 |
Efficacy and Safety Study of Peginterferon Alfa-2b in Chinese Chronic Hepatitis C Patients |
https://ClinicalTrials.gov/show/NCT01581398 |
Completed |
Xiamen Amoytop Biotech Co., Ltd. |
2014-04-30 |
| NCT01581138 |
VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis C |
https://ClinicalTrials.gov/show/NCT01581138 |
Completed |
Vertex Pharmaceuticals Incorporated |
2013-06-30 |
| NCT01580995 |
Herpes Simplex Type 1 Suppression in Hepatitis C |
https://ClinicalTrials.gov/show/NCT01580995 |
Completed |
VA Office of Research and Development |
2014-12-31 |
| NCT01532843 |
Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Treatment to Ncrease Sustained Response in CHB |
https://ClinicalTrials.gov/show/NCT01532843 |
Completed |
Foundation for Liver Research |
2015-08-31 |
| NCT01522625 |
Tenofovir in Chronic Hepatitis B With Mild ALT Elevation |
https://ClinicalTrials.gov/show/NCT01522625 |
Completed |
E-DA Hospital |
2018-11-30 |
| NCT01516918 |
A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT01516918 |
Completed |
Vertex Pharmaceuticals Incorporated |
2013-09-30 |
| NCT01513941 |
An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1) |
https://ClinicalTrials.gov/show/NCT01513941 |
Completed |
Janssen-Cilag International NV |
2014-03-31 |
| NCT01509391 |
Keyhole Limpet Hemocyanin in Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01509391 |
Completed |
Medical University of Graz |
2012-10-31 |
| NCT01498068 |
Open-Label, Bridging Study of Telaprevir in Treatment-Naïve and Treatment-Experienced Russian Patients With Genotype 1 Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01498068 |
Completed |
Janssen-Cilag International NV |
2012-04-30 |
| NCT01480492 |
Effect of Antiviral Therapy on Host Immune in Patients With Chronic Hepatitis B Virus(HBV) Infection |
https://ClinicalTrials.gov/show/NCT01480492 |
Completed |
Changhai Hospital |
2011-10-31 |
| NCT01480284 |
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue |
https://ClinicalTrials.gov/show/NCT01480284 |
Completed |
GlaxoSmithKline |
2013-01-31 |
| NCT01475851 |
Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs |
https://ClinicalTrials.gov/show/NCT01475851 |
Completed |
GlaxoSmithKline |
2013-06-30 |
| NCT01471535 |
HBsAg Clearance in Inactive Chronic HBsAg Carriers After Interferon Treated |
https://ClinicalTrials.gov/show/NCT01471535 |
Completed |
Beijing Ditan Hospital |
2012-12-31 |
| NCT01464827 |
ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients |
https://ClinicalTrials.gov/show/NCT01464827 |
Completed |
AbbVie |
2013-03-31 |
| NCT01453075 |
Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I) |
https://ClinicalTrials.gov/show/NCT01453075 |
Completed |
VA Office of Research and Development |
2015-07-31 |
| NCT01439373 |
Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects |
https://ClinicalTrials.gov/show/NCT01439373 |
Completed |
GlaxoSmithKline |
2011-12-05 |
| NCT01433887 |
Response to Pegylated Interferon and Ribavirin in Chinese Patients With Chronic Hepatitis C Genotypes 1 Versus 2/3 Versus 6 |
https://ClinicalTrials.gov/show/NCT01433887 |
Completed |
Third Affiliated Hospital, Sun Yat-Sen University |
2014-06-30 |
| NCT01425203 |
The Effect of Boceprevir in Russian Participants Diagnosed With Chronic Hepatitis C Genotype 1 (P08160) |
https://ClinicalTrials.gov/show/NCT01425203 |
Completed |
Merck Sharp & Dohme Corp. |
2013-10-21 |
| NCT01413360 |
The Effect of High Dose Vitamin C on the Liver Function in Chronic Hepatitis Patients |
https://ClinicalTrials.gov/show/NCT01413360 |
Completed |
Seoul National University Hospital |
2013-12-31 |
| NCT01379508 |
Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept |
https://ClinicalTrials.gov/show/NCT01379508 |
Completed |
Novartis |
2015-12-10 |
| NCT01378104 |
100% VS 80% Of Pegasys In Koreans With Chronic Hepatitis C (CHC) |
https://ClinicalTrials.gov/show/NCT01378104 |
Completed |
The Catholic University of Korea |
2011-09-30 |
| NCT01373684 |
PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT01373684 |
Completed |
Foundation for Liver Research |
2019-10-28 |
| NCT01355289 |
Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501 |
https://ClinicalTrials.gov/show/NCT01355289 |
Completed |
Eisai Inc. |
2014-02-28 |
| NCT01337791 |
Efficacy, Safety and Tolerability of Telbivudine in HBeAg Positive Chronic Hepatitis B Pregnant Women With Elevated Alanine Aminotransferase Levels |
https://ClinicalTrials.gov/show/NCT01337791 |
Completed |
Southeast University, China |
2009-12-31 |
| NCT01326546 |
Therapeutic Hepatitis B Vaccine (Mimogen-based) Joint Entecavir in Treating Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT01326546 |
Completed |
Chongqing Jiachen Biotechnology Ltd. |
2014-01-31 |
| NCT01320943 |
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB |
https://ClinicalTrials.gov/show/NCT01320943 |
Completed |
Gilead Sciences |
2016-07-28 |
| NCT04423393 |
Study of VIR-3434 in Healthy Volunteers and Patients With Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT04423393 |
Recruiting |
Vir Biotechnology, Inc. |
2022-08-31 |
| NCT04398134 |
A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT04398134 |
Recruiting |
Assembly Biosciences |
2023-01-19 |
| NCT04387526 |
Sofosbuvir Plus Daclatasvir With or Without Ribavirin and Chronic HCV Genotype (GT) 4 |
https://ClinicalTrials.gov/show/NCT04387526 |
Completed |
Beni-Suef University |
2017-05-31 |
| NCT04318379 |
Therapeutic Hepatitis C Virus Vaccine |
https://ClinicalTrials.gov/show/NCT04318379 |
Recruiting |
GeneCure Biotechnologies |
2022-02-28 |
| NCT04246723 |
Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Sofosbuvir in Treatment-naïve Patients With Chronic Hepatitis C Genotype 1 |
https://ClinicalTrials.gov/show/NCT04246723 |
Recruiting |
R-Pharm |
2022-01-01 |
| NCT04201275 |
The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC74647 in HCV-infected Subjects |
https://ClinicalTrials.gov/show/NCT04201275 |
Completed |
Sunshine Lake Pharma Co., Ltd. |
2020-01-17 |
| NCT04198584 |
Study of Telemedicine Stress Management and Lifestyle Group Intervention for HCV Patients |
https://ClinicalTrials.gov/show/NCT04198584 |
Recruiting |
University of North Carolina, Chapel Hill |
2021-01-15 |
| NCT04195074 |
Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Chronic Hepatitis b |
https://ClinicalTrials.gov/show/NCT04195074 |
Recruiting |
Third Affiliated Hospital, Sun Yat-Sen University |
2023-12-31 |
| NCT04182321 |
Adding Metformin to the Standard Treatment for Patients With HBeAg-Negative Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT04182321 |
Recruiting |
Beijing 302 Hospital |
2021-12-31 |
| NCT04180150 |
A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT04180150 |
Recruiting |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2020-09-30 |
| NCT04157699 |
An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Tenofovir in Naive Patients With Chronic Hepatitis b |
https://ClinicalTrials.gov/show/NCT04157699 |
Recruiting |
Qilu Pharmaceutical Co., Ltd. |
2020-12-31 |
| NCT04157257 |
An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Entecavir or Tenofovir in Patients With Chronic Hepatitis b Who Have Received Nucleoside (Acid) Therapy |
https://ClinicalTrials.gov/show/NCT04157257 |
Recruiting |
Qilu Pharmaceutical Co., Ltd. |
2020-12-31 |
| NCT04112147 |
A Randomized, Placebo-controlled Trial of Antroquinonol in Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT04112147 |
Recruiting |
Chung Shan Medical University |
2020-06-30 |
| NCT04102176 |
Halting Nucleoside Analogues in Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT04102176 |
Recruiting |
National University Health System, Singapore |
2021-03-31 |
| NCT04069858 |
Maintaining Antiviral Efficacy After Switching to Generic Entecavir 1 mg for Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT04069858 |
Active, not recruiting |
Korea University |
2019-03-01 |
| NCT03995485 |
KW-136 With Sofosbuvir for Chinese Adults With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT03995485 |
Completed |
Kawin Technology Share-holding Co., Ltd. |
2018-01-25 |
| NCT03905655 |
Study of Nitazoxanide Compared to Placebo in Subjects With HBeAG-Negative Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03905655 |
Recruiting |
Romark Laboratories L.C. |
2022-12-01 |
| NCT03801798 |
A Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT03801798 |
Active, not recruiting |
Green Cross Corporation |
2021-12-31 |
| NCT03801538 |
The Optimizing Treatment of Peginterferon Alpha in Chronic Hepatitis B Patients With Low Level HBsAg |
https://ClinicalTrials.gov/show/NCT03801538 |
Active, not recruiting |
Third Affiliated Hospital, Sun Yat-Sen University |
2020-12-31 |
| NCT03792919 |
Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK) |
https://ClinicalTrials.gov/show/NCT03792919 |
Recruiting |
Humanity & Health Medical Group Limited |
2023-12-31 |
| NCT03780543 |
A Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT03780543 |
Active, not recruiting |
Assembly Biosciences |
2021-06-30 |
| NCT03723824 |
Grazoprevir/Elbasvir for Genotype 1b Chronic Hepatitis C After Liver or Kidney Transplantation |
https://ClinicalTrials.gov/show/NCT03723824 |
Recruiting |
Taichung Veterans General Hospital |
2021-11-30 |
| NCT03714152 |
A Study of ABI-H2158 in Healthy Volunteers and Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03714152 |
Recruiting |
Assembly Biosciences |
2020-08-31 |
| NCT03672188 |
Study of VIR-2218 in Healthy Volunteers and Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03672188 |
Active, not recruiting |
Vir Biotechnology, Inc. |
2021-03-31 |
| NCT03638076 |
The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate Capsules |
https://ClinicalTrials.gov/show/NCT03638076 |
Recruiting |
Sunshine Lake Pharma Co., Ltd. |
2018-12-09 |
| NCT03615066 |
Safety, Tolerability, and Antiviral Activity of Selgantolimod in Viremic Adults With Chronic Hepatitis B Who Are Not Currently on Treatment |
https://ClinicalTrials.gov/show/NCT03615066 |
Active, not recruiting |
Gilead Sciences |
2019-12-12 |
| NCT03612973 |
Changes in Liver Fibrosis, Lipid Profile and Insulin Resistance in HCV Patients Who Received Antiviral Therapy |
https://ClinicalTrials.gov/show/NCT03612973 |
Recruiting |
Assiut University |
2021-10-31 |
| NCT03585322 |
APG-1387 Study of Safety, Tolerability ,PK/PD in Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03585322 |
Recruiting |
Ascentage Pharma Group Inc. |
2021-10-30 |
| NCT03577171 |
A Study Evaluating ABI-H0731+ NUC vs NUC Alone for the Treatment of Viremic HBeAg-positive, CHB Patients |
https://ClinicalTrials.gov/show/NCT03577171 |
Completed |
Assembly Biosciences |
2019-06-21 |
| NCT03576066 |
A Study Evaluating ABI-H0731 as Adjunctive Therapy in Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03576066 |
Completed |
Assembly Biosciences |
2019-07-05 |
| NCT03575208 |
Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03575208 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2022-05-30 |
| NCT03546621 |
A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis D |
https://ClinicalTrials.gov/show/NCT03546621 |
Completed |
Hepatera Ltd. |
2018-01-31 |
| NCT03491553 |
Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Adults With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03491553 |
Active, not recruiting |
Gilead Sciences |
2019-03-22 |
| NCT03490097 |
Statins in Chronic Hepatitis C Patients Receiving Sofosbuvir/Daclatasvir Combination |
https://ClinicalTrials.gov/show/NCT03490097 |
Completed |
Ain Shams University |
2018-05-23 |
| NCT03488485 |
Management of Patients With Hepatitis C in a Public Health Care Setting: The Punjab Model |
https://ClinicalTrials.gov/show/NCT03488485 |
Recruiting |
Postgraduate Institute of Medical Education and Research |
2020-12-31 |
| NCT03487848 |
Evaluation of Daclatasvir (DCV) in Combination With Sofosbuvir (SOF) in Children With Chronic Hepatitis C (CHC) Infection |
https://ClinicalTrials.gov/show/NCT03487848 |
Active, not recruiting |
Bristol-Myers Squibb |
2018-10-11 |
| NCT03485846 |
Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Daclatasvir in Treatment-NaÑ—ve Patients With Chronic Hepatitis C Genotype 1b |
https://ClinicalTrials.gov/show/NCT03485846 |
Completed |
R-Pharm |
2018-08-29 |
| NCT03483987 |
Re-treatment of HCV Following DAA Failure |
https://ClinicalTrials.gov/show/NCT03483987 |
Recruiting |
Sanjay Gandhi Postgraduate Institute of Medical Sciences |
2021-01-09 |
| NCT03481036 |
DAA Therapy in Pediatric Patients With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT03481036 |
Recruiting |
Postgraduate Institute of Medical Education and Research |
2020-12-31 |
| NCT03439488 |
A Study of Orally Administered JNJ-440 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Single Ascending Doses Including Food Effect Evaluation; After Multi-Day Dosing in Healthy Participants; and After Multiple (Ascending) Doses in Participants With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03439488 |
Completed |
Alios Biopharma Inc. |
2019-10-10 |
| NCT03429439 |
Study on Effect of Intestinal Microbiota Transplantation in Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03429439 |
Recruiting |
Zhongshan Hospital Xiamen University |
2020-10-31 |
| NCT01264367 |
A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+) |
https://ClinicalTrials.gov/show/NCT01264367 |
Completed |
Bukwang Pharmaceutical |
2013-08-31 |
| NCT01264354 |
An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01264354 |
Completed |
Bukwang Pharmaceutical |
2012-08-31 |
| NCT01260350 |
Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3 |
https://ClinicalTrials.gov/show/NCT01260350 |
Completed |
Gilead Sciences |
2013-10-31 |
| NCT01241760 |
VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT01241760 |
Completed |
Janssen Infectious Diseases BVBA |
2012-08-31 |
| NCT03434353 |
Study to Evaluate the Antiviral Activity of Inarigivir Soproxil (GS-9992) Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Adults With Chronic Hepatitis B (CHB) |
https://ClinicalTrials.gov/show/NCT03434353 |
Active, not recruiting |
Gilead Sciences |
2020-01-20 |
| NCT01225380 |
A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01225380 |
Completed |
Gilead Sciences |
2013-01-31 |
| NCT01221298 |
A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABT-450 With Ritonavir (ABT-450/r) Dosed in Combination With ABT-072 and Ribavirin (RBV) |
https://ClinicalTrials.gov/show/NCT01221298 |
Completed |
AbbVie |
2011-05-31 |
| NCT01195181 |
Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice. |
https://ClinicalTrials.gov/show/NCT01195181 |
Completed |
Azienda Ospedaliera di Padova |
2009-12-31 |
| NCT01192854 |
An Study of Efficacy and Safety of Clevudine |
https://ClinicalTrials.gov/show/NCT01192854 |
Completed |
Eisai Inc. |
2011-05-31 |
| NCT01178996 |
Thymosin Alpha-1 in Combination With Peg-Interferon Alfa- 2a and Ribavirin for the Therapy of Chronic Hepatitis C Nonresponsive to the Combination of IFN and Ribavirin. |
https://ClinicalTrials.gov/show/NCT01178996 |
Completed |
sigma-tau i.f.r. S.p.A. |
2008-05-31 |
| NCT01144936 |
Study of VX-985 in Subjects With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01144936 |
Completed |
Vertex Pharmaceuticals Incorporated |
2010-10-31 |
| NCT01143662 |
Efficacy and Safety of Ypeginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01143662 |
Completed |
Xiamen Amoytop Biotech Co., Ltd. |
2011-04-30 |
| NCT01140997 |
Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01140997 |
Completed |
Xiamen Amoytop Biotech Co., Ltd. |
2011-01-31 |
| NCT01121731 |
A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01121731 |
Completed |
Digna Biotech S.L. |
2012-10-31 |
| NCT01120795 |
Pegylated Interferon and Ribavirin in Hepatitis C Patients on Opioid Pharmacotherapy |
https://ClinicalTrials.gov/show/NCT01120795 |
Completed |
Melbourne Health |
2006-01-31 |
| NCT01113814 |
Acoustic Radiation Force Impulse-Imaging in Comparison to Transient Elastography for Liver Fibrosis Staging in HCV |
https://ClinicalTrials.gov/show/NCT01113814 |
Completed |
Johann Wolfgang Goethe University Hospital |
NA |
| NCT01098006 |
A Study in Adult Subjects With Chronic Hepatitis B Infection to Support the Development of Immunological Assays |
https://ClinicalTrials.gov/show/NCT01098006 |
Completed |
GlaxoSmithKline |
2012-02-20 |
| NCT01090232 |
Host Responses in Kidney-transplant Recipients With Chronic Hepatitis E Virus Infection |
https://ClinicalTrials.gov/show/NCT01090232 |
Completed |
Assistance Publique Hopitaux De Marseille |
2012-02-29 |
| NCT01088009 |
Efficacy Optimizing Research of Lamivudine Therapy |
https://ClinicalTrials.gov/show/NCT01088009 |
Completed |
Nanfang Hospital of Southern Medical University |
2013-02-28 |
| NCT01079806 |
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT01079806 |
Completed |
Bristol-Myers Squibb |
2013-03-31 |
| NCT01074008 |
A Randomized Study to Evaluate the Safety, Tolerability and Antiviral Activity of ABT-450, ABT-333 and ABT-072 |
https://ClinicalTrials.gov/show/NCT01074008 |
Completed |
AbbVie |
2011-06-30 |
| NCT01063036 |
Efficacy and Safety Study of Entecavir Plus Tenofovir in Patients With Chronic Hepatitis B Who Failed Previous Treatment |
https://ClinicalTrials.gov/show/NCT01063036 |
Completed |
Bristol-Myers Squibb |
2012-11-30 |
| NCT01037166 |
Study in Japan of the Safety And Antiviral Activity in Adults With Chronic Hepatitis B Current Lamivudine Therapy |
https://ClinicalTrials.gov/show/NCT01037166 |
Completed |
Bristol-Myers Squibb |
2005-02-28 |
| NCT01037062 |
An Open-Label Rollover Study of Entecavir (BMS-200475) in Adults With Chronic Hepatitis B Infection |
https://ClinicalTrials.gov/show/NCT01037062 |
Completed |
Bristol-Myers Squibb |
2006-12-31 |
| NCT01026610 |
Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01026610 |
Completed |
LG Life Sciences |
2010-11-30 |
| NCT01023217 |
Entecavir Plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Patients Who Fail Lamivudine Plus Adefovir |
https://ClinicalTrials.gov/show/NCT01023217 |
Completed |
Asan Medical Center |
2012-07-31 |
| NCT01022801 |
A Phase II Dose Response Study in Japan in Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01022801 |
Completed |
Bristol-Myers Squibb |
2005-03-31 |
| NCT01020565 |
A Study in Japan of the Safety and Antiviral Activity With Chronic Hepatitis B Infection |
https://ClinicalTrials.gov/show/NCT01020565 |
Completed |
Bristol-Myers Squibb |
2005-02-28 |
| NCT01018615 |
Safety, Metabolism, and Antioxidant Activity of Silymarin and Green Tea Extract in Patients With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01018615 |
Completed |
University of North Carolina, Chapel Hill |
2013-04-30 |
| NCT01012895 |
Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care |
https://ClinicalTrials.gov/show/NCT01012895 |
Completed |
Bristol-Myers Squibb |
2012-10-31 |
| NCT01011166 |
Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin (MK-2355-004) |
https://ClinicalTrials.gov/show/NCT01011166 |
Completed |
Merck Sharp & Dohme Corp. |
2010-07-31 |
| NCT00988767 |
Safety and Immunogenicity of a Naked DNA-based Vaccine Therapy in Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00988767 |
Completed |
Institut National de la Santé Et de la Recherche Médicale, France |
2003-11-30 |
| NCT00983060 |
Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected Patients |
https://ClinicalTrials.gov/show/NCT00983060 |
Completed |
Novartis |
2011-04-30 |
| NCT00975091 |
Continue Entecavir Rollover From China |
https://ClinicalTrials.gov/show/NCT00975091 |
Completed |
Bristol-Myers Squibb |
2007-08-31 |
| NCT00973817 |
Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Acute on Chronic Hepatitis |
https://ClinicalTrials.gov/show/NCT00973817 |
Completed |
Vital Therapies, Inc. |
2011-04-30 |
| NCT00973219 |
Hepatitis B Surface Antigen(HBsAg) Loss in Chronic Hepatitis B Patients With Low Viral Load |
https://ClinicalTrials.gov/show/NCT00973219 |
Active, not recruiting |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2019-11-30 |
| NCT00968357 |
Proof-of-concept Study to Evaluate the Safety and Immunomodulatory Effects of SCV 07 as Monotherapy or in Combination With Ribavirin in Noncirrhotic Subjects With Chronic Hepatitis C Who Have Relapsed |
https://ClinicalTrials.gov/show/NCT00968357 |
Completed |
SciClone Pharmaceuticals |
2011-01-31 |
| NCT00944684 |
High Dose Ribavirin in the Treatment of Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT00944684 |
Completed |
University of Bern |
2011-04-30 |
| NCT00936715 |
Rollover Protocol Continued Access to Emtricitabine/Tenofovir Disoproxil Fumarate for Adults in United States |
https://ClinicalTrials.gov/show/NCT00936715 |
Completed |
Gilead Sciences |
2015-11-30 |
| NCT00926016 |
Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 Subjects |
https://ClinicalTrials.gov/show/NCT00926016 |
Completed |
Brooke Army Medical Center |
2010-03-31 |
| NCT00909129 |
Interactions of Hepatitis C Viral (HCV) Dynamics and Immune Activation in HIV Coinfected Patients During HCV Treatment |
https://ClinicalTrials.gov/show/NCT00909129 |
Completed |
Karolinska Institutet |
NA |
| NCT00907894 |
Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00907894 |
Completed |
Novartis |
2012-03-31 |
| NCT00895596 |
Safety and Efficacy Study of LB80380 in the Patients With Lamivudine-Refractory Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00895596 |
Completed |
LG Life Sciences |
2006-08-31 |
| NCT00883844 |
PEG-IFN in HBV Patients With Incomplete Response to NA |
https://ClinicalTrials.gov/show/NCT00883844 |
Completed |
Foundation for Liver Research |
2012-06-30 |
| NCT00881582 |
Peginterferon Alfa-2a Plus Ribavirin Combination Treatment in Chronic Hepatitis C Post-Renal Transplant Patients |
https://ClinicalTrials.gov/show/NCT00881582 |
Completed |
King Abdulaziz Medical City |
2011-12-31 |
| NCT00877760 |
Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00877760 |
Completed |
Foundation for Liver Research |
2013-07-31 |
| NCT00877149 |
Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00877149 |
Completed |
Novartis |
2011-04-30 |
| NCT00869778 |
Phase 2 Trial of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00869778 |
Completed |
Chongqing Jiachen Biotechnology Ltd. |
2011-11-30 |
| NCT00857675 |
A Efficacy and Safety Study of Adefovir Dipivoxil to Treat Chinese Patients With HBeAg+ve Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00857675 |
Completed |
GlaxoSmithKline |
2008-03-31 |
| NCT00854802 |
A Study of Debio 025 (Alisporivir) Combined With Peg-IFNα2a and Ribavirin in Treatment naïve Chronic Hepatitis C Genotype 1 Patients |
https://ClinicalTrials.gov/show/NCT00854802 |
Completed |
Debiopharm International SA |
2010-09-30 |
| NCT00854087 |
Assess the Antifibrotic Activity of Fuzheng Huayu in Chronic Hepatitis C Patients With Hepatic Fibrosis |
https://ClinicalTrials.gov/show/NCT00854087 |
Completed |
SCTI Research Foundation |
2013-04-30 |
| NCT00851890 |
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Multiple Doses of ABT-333 Alone and in Combination With Pegylated Interferon (pegIFN) and Ribavirin (RBV) in Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection |
https://ClinicalTrials.gov/show/NCT00851890 |
Completed |
AbbVie |
2009-07-31 |
| NCT00844272 |
Psychoeducation Reaches HCV-infected Methadone/Buprenorphine Substituted Patients in Standard Antiviral Treatment |
https://ClinicalTrials.gov/show/NCT00844272 |
Completed |
Universitätsklinikum Hamburg-Eppendorf |
2008-11-30 |
| NCT02862106 |
Second Stage:Open-label Study of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT02862106 |
Completed |
Chongqing Jiachen Biotechnology Ltd. |
2013-03-31 |
| NCT00830609 |
High Dose Versus Standard Dose of Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 |
https://ClinicalTrials.gov/show/NCT00830609 |
Completed |
Hospital Universitario Fundación Alcorcón |
2011-09-30 |
| NCT00828269 |
Evaluation of RNA From the Liver Tissue Obtained in Patients With Chronic Hepatitis C (0000-123) |
https://ClinicalTrials.gov/show/NCT00828269 |
Completed |
Merck Sharp & Dohme Corp. |
2010-02-28 |
| NCT00823862 |
Safety Study of SD-101 (a Novel C Type Toll-like Receptor 9 (TLR9) Agonist) for the Treatment of Chronic Hepatitis C Virus (HCV) Infection |
https://ClinicalTrials.gov/show/NCT00823862 |
Completed |
Dynavax Technologies Corporation |
2009-12-31 |
| NCT03778567 |
Renoprotective Effects of Telbivudine in Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03778567 |
Completed |
The University of Hong Kong |
2016-06-16 |
| NCT03501550 |
Study of CDI-31244 in Combination With Sofosbuvir (SOF) and Velpatasvir (VEL) |
https://ClinicalTrials.gov/show/NCT03501550 |
Completed |
Cocrystal Pharma, Inc. |
2019-01-08 |
| NCT01524679 |
Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen |
https://ClinicalTrials.gov/show/NCT01524679 |
Completed |
Johannes Gutenberg University Mainz |
2017-08-28 |
| NCT00807001 |
Double-Blind, Dose-Escalation Study of IDX184 in Chronic Hepatitis C Treatment-Naïve Subjects |
https://ClinicalTrials.gov/show/NCT00807001 |
Completed |
Merck Sharp & Dohme Corp. |
2009-07-31 |
| NCT00804622 |
Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB) |
https://ClinicalTrials.gov/show/NCT00804622 |
Completed |
The University of Hong Kong |
2009-06-30 |
| NCT02979613 |
Efficacy and Safety of Switching From TDF to TAF in Adults With Chronic Hepatitis B Who Are Virologically Suppressed |
https://ClinicalTrials.gov/show/NCT02979613 |
Completed |
Gilead Sciences |
2018-09-10 |
| NCT02642432 |
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT02642432 |
Completed |
AbbVie |
2016-10-27 |
| NCT02637999 |
Myrcludex B Plus Pegylated Interferon-alpha-2a in Patients With HBeAg Negative HBV/HDV Co-infection |
https://ClinicalTrials.gov/show/NCT02637999 |
Completed |
Hepatera Ltd. |
2016-01-21 |
| NCT02636595 |
The Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 4, 5, or 6 Infection (ENDURANCE-4) |
https://ClinicalTrials.gov/show/NCT02636595 |
Completed |
AbbVie |
2016-10-31 |
| NCT02579382 |
Study to Evaluate the Safety, Tolerability, and Efficacy of Vesatolimod in Combination With Tenofovir Disoproxil Fumarate (TDF) in Adults With Chronic Hepatitis B (CHB) Infection Who Are Currently Not Being Treated |
https://ClinicalTrials.gov/show/NCT02579382 |
Completed |
Gilead Sciences |
2017-01-16 |
| NCT02027116 |
Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of VGX-6150 for Second-line Therapy of Chronic Hepatitis C Infection |
https://ClinicalTrials.gov/show/NCT02027116 |
Completed |
GeneOne Life Science, Inc. |
2015-07-31 |
| NCT02123212 |
Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C |
https://ClinicalTrials.gov/show/NCT02123212 |
Completed |
National Opinion Research Center |
2014-03-31 |
| NCT00793793 |
Safety, Antiviral Activity and PK of MRD of BI 201335 in Chronic Hepatitis C Patients Both Treatment Naive and -Experienced |
https://ClinicalTrials.gov/show/NCT00793793 |
Completed |
Boehringer Ingelheim |
2011-01-31 |
| NCT00790673 |
A Phase 1/2 Study of CF102 in Patients With Chronic Hepatitis C Genotype 1 |
https://ClinicalTrials.gov/show/NCT00790673 |
Completed |
Can-Fite BioPharma |
2011-06-30 |
| NCT00788918 |
Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS) |
https://ClinicalTrials.gov/show/NCT00788918 |
Completed |
University of Aarhus |
2012-11-30 |
| NCT00782353 |
Safety, Tolerability, and Antiviral Activity of ANA598 in Patients With Genotype-1 Chronic HCV Infection |
https://ClinicalTrials.gov/show/NCT00782353 |
Completed |
Hoffmann-La Roche |
2009-03-31 |
| NCT00781105 |
Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00781105 |
Completed |
Novartis |
2010-09-16 |
| NCT00780910 |
Efficacy and Safety of MP-424, Peginterferon Alfa-2b, and Ribavirin in Patients With Chronic Hepatitis C Who Relapsed After Previous Interferon Based Therapy |
https://ClinicalTrials.gov/show/NCT00780910 |
Completed |
Mitsubishi Tanabe Pharma Corporation |
2010-10-31 |
| NCT00778843 |
Antioxidant and Immunomodulator Properties of Viusid in Patients With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT00778843 |
Completed |
Catalysis SL |
2009-05-31 |
| NCT00771446 |
Safety & Efficacy of the Extracorporeal Liver Assist Device (ELAD) System in Patients With Hepatic Insufficiency |
https://ClinicalTrials.gov/show/NCT00771446 |
Completed |
Vital Therapies, Inc. |
2009-04-30 |
| NCT00763568 |
4-Week Lead-In With Nitazoxanide Followed by 36 Weeks Nitazoxanide and Peginterferon Alfa-2a in Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT00763568 |
Completed |
Romark Laboratories L.C. |
2008-09-30 |
| NCT00759200 |
Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients |
https://ClinicalTrials.gov/show/NCT00759200 |
Completed |
Novartis |
2010-12-31 |
| NCT00749138 |
Fourteen Day Safety of Low-Dose Tamoxifen in Patients With Chronic Hepatitis C Who Have Failed Standard Medical Therapy |
https://ClinicalTrials.gov/show/NCT00749138 |
Completed |
Bader, Ted, M.D. |
2009-05-31 |
| NCT00736190 |
A Study to Evaluate Tenofovir Disoproxil Fumarate (DF) in Asian-American Adults With Chronic Hepatitis B Infection |
https://ClinicalTrials.gov/show/NCT00736190 |
Completed |
Gilead Sciences |
2010-07-31 |
| NCT00735969 |
High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1 |
https://ClinicalTrials.gov/show/NCT00735969 |
Completed |
National Institutes of Health Clinical Center (CC) |
2013-06-30 |
| NCT00734162 |
Evaluation of Tenofovir Disoproxil Fumarate in Adolescents With Chronic Hepatitis B Infection |
https://ClinicalTrials.gov/show/NCT00734162 |
Completed |
Gilead Sciences |
2011-03-31 |
| NCT00724776 |
Albinterferon Alfa 2b Single Dose in Japanese Chronic Hepatitis C Patients |
https://ClinicalTrials.gov/show/NCT00724776 |
Completed |
Novartis |
2009-07-31 |
| NCT00680342 |
Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment |
https://ClinicalTrials.gov/show/NCT00680342 |
Completed |
National Center for Complementary and Integrative Health (NCCIH) |
2011-01-31 |
| NCT00680173 |
Peripheral Blood Mononuclear Cell (PBMC) Gene Expression in HCV Genotype 1 Patients |
https://ClinicalTrials.gov/show/NCT00680173 |
Completed |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2016-03-31 |
| NCT00671671 |
Phase 1 Study To Evaluate Antiviral Activity Of Small Molecule Direct Antiviral Agent At Multiple Doses In Subjects With Chronically Infected Hepatitis C Virus. |
https://ClinicalTrials.gov/show/NCT00671671 |
Completed |
Pfizer |
2008-12-31 |
| NCT00656006 |
A Study of Albuferon With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 or 3 |
https://ClinicalTrials.gov/show/NCT00656006 |
Completed |
Human Genome Sciences Inc. |
2007-04-30 |
| NCT00641082 |
A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver Function |
https://ClinicalTrials.gov/show/NCT00641082 |
Completed |
Bukwang Pharmaceutical |
2012-03-31 |
| NCT00630084 |
Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT00630084 |
Completed |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2008-10-31 |
| NCT00629967 |
A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients |
https://ClinicalTrials.gov/show/NCT00629967 |
Completed |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2007-05-31 |
| NCT00629824 |
Pegylated Interferon Plus Ribavirin in Treating Older Patients With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT00629824 |
Completed |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2009-04-30 |
| NCT00606086 |
Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C Infection |
https://ClinicalTrials.gov/show/NCT00606086 |
Completed |
GlobeImmune |
2012-11-30 |
| NCT00596960 |
Study of the Effects of Motivational Enhancement Therapy on Alcohol Use in Chronic Hepatitis C Patients |
https://ClinicalTrials.gov/show/NCT00596960 |
Completed |
VA Office of Research and Development |
2012-06-30 |
| NCT00596414 |
Sedation and Analgesia for Transjugular Liver Biopsy: A Randomized Double Blind Placebo Controlled Trial |
https://ClinicalTrials.gov/show/NCT00596414 |
Completed |
Erasme University Hospital |
2005-10-31 |
| NCT00591214 |
Safety and PK Study of MP-424 to Treat Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT00591214 |
Completed |
Mitsubishi Tanabe Pharma Corporation |
2008-10-31 |
| NCT00558493 |
Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT00558493 |
Completed |
Bukwang Pharmaceutical |
NA |
| NCT00546442 |
Treatment Insulin Resistence in HCV G-1 Patient |
https://ClinicalTrials.gov/show/NCT00546442 |
Completed |
Valme University Hospital |
NA |
| NCT00528528 |
An Open-Label Study of Telaprevir Administered Every 12 or 8 Hours in Combination With One of Two Pegylated Interferons and Ribavirin in Treatment-Naive Genotype 1 Chronic Hepatitis C Participants |
https://ClinicalTrials.gov/show/NCT00528528 |
Completed |
Tibotec BVBA |
2009-07-31 |
| NCT00540345 |
Four Arms, Multicenter Study of Tailored Regimens With Peginterferon Plus Ribavirin for Genotype 2 Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT00540345 |
Completed |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2013-12-31 |
| NCT00536627 |
Efficacy and Tolerance of Naked DNA Vaccine in Patients With Chronic B Hepatitis |
https://ClinicalTrials.gov/show/NCT00536627 |
Completed |
French National Agency for Research on AIDS and Viral Hepatitis |
2010-11-30 |
| NCT00532701 |
Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR |
https://ClinicalTrials.gov/show/NCT00532701 |
Completed |
National Taiwan University Hospital |
2014-03-31 |
| NCT00531167 |
Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00531167 |
Completed |
Korea University |
2011-04-30 |
| NCT00530972 |
Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous Therapies |
https://ClinicalTrials.gov/show/NCT00530972 |
Completed |
Hospital Carlos III, Madrid |
2008-12-31 |
| NCT00519792 |
Phase 1b Study of Omega DUROS® in Patients With Chronic Hepatitis C Who Relapsed After Prior Treatment |
https://ClinicalTrials.gov/show/NCT00519792 |
Completed |
Intarcia Therapeutics |
2010-03-31 |
| NCT00513968 |
Phase I Study to Investigate the Safety and Efficacy of HBV DNA Vaccine |
https://ClinicalTrials.gov/show/NCT00513968 |
Completed |
Genexine, Inc. |
2010-04-30 |
| NCT00507689 |
Truvada Versus Truvada Plus Hepatitis B Immunoglobulin (HBIg) in Prevention of Chronic Hepatitis B Recurrence Post Liver Transplant |
https://ClinicalTrials.gov/show/NCT00507689 |
Completed |
Gilead Sciences |
2011-05-31 |
| NCT00507507 |
A Study to Compare Tenofovir DF Versus the Combination of Emtricitabine Plus Tenofovir DF for the Treatment of Chronic Hepatitis B in Patients With Normal Alanine Aminotransferase (ALT) |
https://ClinicalTrials.gov/show/NCT00507507 |
Completed |
Gilead Sciences |
2012-02-29 |
| NCT00503347 |
Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus |
https://ClinicalTrials.gov/show/NCT00503347 |
Completed |
Peregrine Pharmaceuticals |
2011-03-31 |
| NCT00502099 |
Comparison of Pegasys Versus Peg-Intron for Treatment of Chronic Hepatitis C Genotype 4 |
https://ClinicalTrials.gov/show/NCT00502099 |
Completed |
Ain Shams University |
2009-05-31 |
| NCT00502086 |
Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection. |
https://ClinicalTrials.gov/show/NCT00502086 |
Completed |
Catalysis SL |
2009-07-31 |
| NCT00491244 |
Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve Hemodialysis Patients With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT00491244 |
Completed |
National Taiwan University Hospital |
2013-09-30 |
| NCT00491179 |
Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin |
https://ClinicalTrials.gov/show/NCT00491179 |
Completed |
National Taiwan University Hospital |
2008-06-30 |
| NCT00487318 |
Fluvastatin, Rosuvastatin Added to Pegylated Interferon and Ribavirin |
https://ClinicalTrials.gov/show/NCT00487318 |
Completed |
Bader, Ted, M.D. |
2010-10-31 |
| NCT00475176 |
S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT00475176 |
Completed |
National Institutes of Health Clinical Center (CC) |
2011-05-31 |
| NCT00467545 |
An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00467545 |
Completed |
Novartis |
2009-09-30 |
| NCT00446134 |
Taribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus (HCV) |
https://ClinicalTrials.gov/show/NCT00446134 |
Completed |
Bausch Health Americas, Inc. |
2008-04-30 |
| NCT00445419 |
Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides |
https://ClinicalTrials.gov/show/NCT00445419 |
Completed |
Pevion Biotech Ltd |
NA |
| NCT00441974 |
Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)Patients |
https://ClinicalTrials.gov/show/NCT00441974 |
Completed |
GlaxoSmithKline |
2008-09-30 |
| NCT00433069 |
Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus Pioglitazone |
https://ClinicalTrials.gov/show/NCT00433069 |
Completed |
University Hospital, Geneva |
2007-12-31 |
| NCT00423670 |
Safety and Efficacy of SCH 503034 in Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03523) |
https://ClinicalTrials.gov/show/NCT00423670 |
Completed |
Merck Sharp & Dohme Corp. |
2008-08-31 |
| NCT00421434 |
Study of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT00421434 |
Completed |
Romark Laboratories L.C. |
2008-09-30 |
| NCT00418639 |
Study of Nitazoxanide in the Treatment of Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT00418639 |
Completed |
Romark Laboratories L.C. |
NA |
| NCT00418054 |
Study of Nitazoxanide Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of Hepatitis C |
https://ClinicalTrials.gov/show/NCT00418054 |
Completed |
Romark Laboratories L.C. |
NA |
| NCT00412529 |
Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00412529 |
Completed |
Novartis |
2008-02-29 |
| NCT00411385 |
Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3 |
https://ClinicalTrials.gov/show/NCT00411385 |
Completed |
Human Genome Sciences Inc. |
2008-10-31 |
| NCT00403585 |
Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814 |
https://ClinicalTrials.gov/show/NCT00403585 |
Completed |
GlaxoSmithKline |
2008-04-30 |
| NCT00402428 |
Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients |
https://ClinicalTrials.gov/show/NCT00402428 |
Completed |
Human Genome Sciences Inc. |
2009-02-28 |
| NCT00395421 |
Study to Evaluate Drug-drug Interaction Between Valopicitabine and Ribavirin |
https://ClinicalTrials.gov/show/NCT00395421 |
Completed |
Merck Sharp & Dohme Corp. |
2008-06-30 |
| NCT00395018 |
Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT00395018 |
Completed |
Bristol-Myers Squibb |
2011-03-31 |
| NCT00393484 |
A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection |
https://ClinicalTrials.gov/show/NCT00393484 |
Completed |
Bristol-Myers Squibb |
2009-01-31 |
| NCT00354653 |
A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B Alone |
https://ClinicalTrials.gov/show/NCT00354653 |
Completed |
ViiV Healthcare |
2007-01-23 |
| NCT00352235 |
Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C Infection |
https://ClinicalTrials.gov/show/NCT00352235 |
Completed |
Foundation for Liver Research |
NA |
| NCT00347009 |
Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis |
https://ClinicalTrials.gov/show/NCT00347009 |
Completed |
GlaxoSmithKline |
2009-09-30 |
| NCT00338780 |
Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia) |
https://ClinicalTrials.gov/show/NCT00338780 |
Completed |
Chinese University of Hong Kong |
NA |
| NCT00324961 |
Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00324961 |
Completed |
GlaxoSmithKline |
2009-01-31 |
| NCT00316719 |
Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT00316719 |
Completed |
GlaxoSmithKline |
2008-01-31 |
| NCT00307489 |
Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil |
https://ClinicalTrials.gov/show/NCT00307489 |
Completed |
Gilead Sciences |
2008-01-31 |
| NCT00307242 |
Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00307242 |
Completed |
Thomas Jefferson University |
NA |
| NCT00304551 |
A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC) |
https://ClinicalTrials.gov/show/NCT00304551 |
Completed |
Chugai Pharmaceutical |
2009-12-31 |
| NCT00299936 |
Comparison of PEG-Intron and Two Different Doses of Ribavirin for the Treatment of Chronic Hepatitis C In Treatment Naïve Subjects |
https://ClinicalTrials.gov/show/NCT00299936 |
Completed |
Weill Medical College of Cornell University |
NA |
| NCT00298714 |
Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT00298714 |
Completed |
Hospital Clinic of Barcelona |
NA |
| NCT00298363 |
Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine (FTC)/TDF, and Entecavir (ETV) in the Treatment of Chronic HBV in Subjects With Decompensated Liver Disease. |
https://ClinicalTrials.gov/show/NCT00298363 |
Completed |
Gilead Sciences |
2011-04-30 |
| NCT00291616 |
Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00291616 |
Completed |
Seoul National University Hospital |
2008-08-31 |
| NCT00287235 |
Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS) |
https://ClinicalTrials.gov/show/NCT00287235 |
Completed |
Baxter Healthcare Corporation |
2003-11-30 |
| NCT00277862 |
Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4 |
https://ClinicalTrials.gov/show/NCT00277862 |
Completed |
Ain Shams University |
2007-03-31 |
| NCT00277576 |
Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B Infection |
https://ClinicalTrials.gov/show/NCT00277576 |
Completed |
PowderMed |
NA |
| NCT00277238 |
CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Non-Responder (Null And Partial Responder) Hepatitis C Virus (HCV) Genotype 1 Infected Subjects |
https://ClinicalTrials.gov/show/NCT00277238 |
Completed |
Pfizer |
2007-07-31 |
| NCT00275938 |
Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00275938 |
Completed |
National Taiwan University Hospital |
NA |
| NCT00262379 |
Use or Non-use of Epoetin Beta in Patients Infected by Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT00262379 |
Completed |
University Hospital, Angers |
2009-06-30 |
| NCT00249860 |
A Multicenter Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian Subjects |
https://ClinicalTrials.gov/show/NCT00249860 |
Completed |
EMD Serono |
2005-08-31 |
| NCT00245414 |
Trial of Pegasys® in Patients With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT00245414 |
Completed |
Chugai Pharmaceutical |
2010-07-31 |
| NCT00230958 |
Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment-Naive |
https://ClinicalTrials.gov/show/NCT00230958 |
Completed |
Bausch Health Americas, Inc. |
2006-01-31 |
| NCT00230854 |
Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin |
https://ClinicalTrials.gov/show/NCT00230854 |
Completed |
OPKO Health, Inc. |
NA |
| NCT00227435 |
Dose Escalation Study to Evaluate the Safety and Antiviral Activity of Val-mCyd in Adults With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT00227435 |
Completed |
Merck Sharp & Dohme Corp. |
2004-07-31 |
| NCT00226447 |
Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT00226447 |
Completed |
Chinese University of Hong Kong |
2006-07-31 |
| NCT00226382 |
Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment |
https://ClinicalTrials.gov/show/NCT00226382 |
Completed |
Chinese University of Hong Kong |
2008-04-30 |
| NCT00215891 |
PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon |
https://ClinicalTrials.gov/show/NCT00215891 |
Completed |
Hepatitis Resource Network |
NA |
| NCT00215865 |
PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy |
https://ClinicalTrials.gov/show/NCT00215865 |
Completed |
Hepatitis Resource Network |
NA |
| NCT00200343 |
Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT00200343 |
Completed |
Mitsubishi Tanabe Pharma Corporation |
NA |
| NCT00199719 |
Study of the Pharmacokinetic Action of Amantadine and Ribavirin in Chronic Hepatitis C. CINAM |
https://ClinicalTrials.gov/show/NCT00199719 |
Completed |
University Hospital, Limoges |
NA |
| NCT00196664 |
Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus Ribavirin |
https://ClinicalTrials.gov/show/NCT00196664 |
Completed |
French National Agency for Research on AIDS and Viral Hepatitis |
NA |
| NCT00196586 |
Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients |
https://ClinicalTrials.gov/show/NCT00196586 |
Completed |
French National Agency for Research on AIDS and Viral Hepatitis |
NA |
| NCT00172809 |
Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal Disease |
https://ClinicalTrials.gov/show/NCT00172809 |
Completed |
National Taiwan University Hospital |
2006-06-30 |
| NCT00162734 |
Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy |
https://ClinicalTrials.gov/show/NCT00162734 |
Completed |
Bausch Health Americas, Inc. |
2007-06-30 |
| NCT00160251 |
Boceprevir (SCH 503034) Plus Peg-Intron, With and Without Added Ribavirin, in Patients With Chronic Hepatitis C, Genotype 1, Who Did Not Respond to Previous Treatment With Peginterferon Alfa Plus Ribavirin (Study P03659AM2)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00160251 |
Completed |
Merck Sharp & Dohme Corp. |
2007-07-31 |
| NCT00158496 |
Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211) |
https://ClinicalTrials.gov/show/NCT00158496 |
Completed |
French National Agency for Research on AIDS and Viral Hepatitis |
NA |
| NCT00146016 |
Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Patients |
https://ClinicalTrials.gov/show/NCT00146016 |
Completed |
UMC Utrecht |
NA |
| NCT00144469 |
A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Patients With Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT00144469 |
Completed |
Chugai Pharmaceutical |
NA |
| NCT00142298 |
Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies |
https://ClinicalTrials.gov/show/NCT00142298 |
Completed |
Novartis |
2009-11-30 |
| NCT00142103 |
CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Relapsed Hepatitis C Virus (HCV) Subjects |
https://ClinicalTrials.gov/show/NCT00142103 |
Completed |
Pfizer |
2007-02-28 |
| NCT00140725 |
Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV) |
https://ClinicalTrials.gov/show/NCT00140725 |
Completed |
GlaxoSmithKline |
NA |
| NCT00132652 |
Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00132652 |
Completed |
Novartis |
2006-12-31 |
| NCT00131742 |
Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00131742 |
Completed |
Novartis |
2007-01-31 |
| NCT00117676 |
A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00117676 |
Completed |
Gilead Sciences |
2007-04-30 |
| NCT00120861 |
Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard Therapy |
https://ClinicalTrials.gov/show/NCT00120861 |
Completed |
Merck Sharp & Dohme Corp. |
NA |
| NCT00120835 |
Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C |
https://ClinicalTrials.gov/show/NCT00120835 |
Completed |
Merck Sharp & Dohme Corp. |
NA |
| NCT00118768 |
A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C |
https://ClinicalTrials.gov/show/NCT00118768 |
Completed |
Merck Sharp & Dohme Corp. |
NA |
| NCT00116805 |
A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Positive Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00116805 |
Completed |
Gilead Sciences |
2007-05-31 |
| NCT00115245 |
Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00115245 |
Completed |
Novartis |
2006-08-31 |
| NCT00107653 |
Latino Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) in Treatment-Naive Patients With Chronic Hepatitis C-Genotype 1. |
https://ClinicalTrials.gov/show/NCT00107653 |
Completed |
Hoffmann-La Roche |
2007-09-30 |
| NCT00100659 |
PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C |
https://ClinicalTrials.gov/show/NCT00100659 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2008-08-31 |
| NCT00096785 |
Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection |
https://ClinicalTrials.gov/show/NCT00096785 |
Completed |
Bristol-Myers Squibb |
2006-01-31 |
| NCT00095121 |
Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00095121 |
Completed |
Gilead Sciences |
2006-05-31 |
| NCT00093093 |
Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive |
https://ClinicalTrials.gov/show/NCT00093093 |
Completed |
Bausch Health Americas, Inc. |
2006-05-31 |
| NCT00086541 |
Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy |
https://ClinicalTrials.gov/show/NCT00086541 |
Completed |
Bausch Health Americas, Inc. |
NA |
| NCT00084279 |
CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders) |
https://ClinicalTrials.gov/show/NCT00084279 |
Completed |
InterMune |
NA |
| NCT02476617 |
Ombitasvir/ABT-450 (Paritaprevir)/Ritonavir With Dasabuvir and Ribavirin (RBV) in Treatment Naive and Treatment Experienced Genotype 1a Hepatitis C Virus Infected Adults |
https://ClinicalTrials.gov/show/NCT02476617 |
Completed |
AbbVie |
2016-08-31 |
| NCT00071201 |
Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00071201 |
Completed |
Gilead Sciences |
2006-03-31 |
| NCT00057265 |
A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00057265 |
Completed |
Novartis |
2006-04-30 |
| NCT00049842 |
Prevention of Disease Progress in Chronic Hepatitis C Patients With Liver Fibrosis (Study P02570AM2)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00049842 |
Completed |
Merck Sharp & Dohme Corp. |
2009-10-31 |
| NCT00048945 |
Efficacy and Safety Study of Pegasys in the Treatment of Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00048945 |
Completed |
Hoffmann-La Roche |
2004-10-31 |
| NCT00036608 |
A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine |
https://ClinicalTrials.gov/show/NCT00036608 |
Completed |
Bristol-Myers Squibb |
2005-02-28 |
| NCT00035789 |
A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen |
https://ClinicalTrials.gov/show/NCT00035789 |
Completed |
Bristol-Myers Squibb |
2005-05-31 |
| NCT00035633 |
A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen |
https://ClinicalTrials.gov/show/NCT00035633 |
Completed |
Bristol-Myers Squibb |
2005-02-28 |
| NCT00028275 |
Gamma Interferon Therapy for Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT00028275 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00028093 |
Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C With and Without Kidney Disease |
https://ClinicalTrials.gov/show/NCT00028093 |
Completed |
National Institutes of Health Clinical Center (CC) |
2010-06-30 |
| NCT00023309 |
Lamivudine and Adefovir to Treat Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00023309 |
Completed |
National Institutes of Health Clinical Center (CC) |
2010-04-30 |
| NCT00001729 |
Combination Drug Therapy for Patients With Hepatitis C |
https://ClinicalTrials.gov/show/NCT00001729 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00687999 |
NIDDM and IR in Combination Therapy for CHC |
https://ClinicalTrials.gov/show/NCT00687999 |
Completed |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2008-06-30 |
| NCT00048724 |
Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients With Cirrhosis (Study P02569) |
https://ClinicalTrials.gov/show/NCT00048724 |
Completed |
Merck Sharp & Dohme Corp. |
2008-04-30 |
| NCT00023153 |
Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection |
https://ClinicalTrials.gov/show/NCT00023153 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001854 |
Long-Term Therapy With Ribavirin for Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT00001854 |
Completed |
National Institutes of Health Clinical Center (CC) |
2007-10-10 |
| NCT00001457 |
Lamivudine for Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00001457 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |